UNIVERSITY OF LOUISVILLE lobbying for UNIVERSITY OF LOUISVILLE

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 16, 2026

Expenses

$60,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Kentucky

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Budget/Appropriations

FY 2026 appropriations including increased funding for university research and infrastructure, NSF Engines, biopharmaceutical manufacturing,biofuels, supply chain security, flood research, trauma, wastewater monitoring, the Regional Biocontainment Laboratories (RBLs),EPSCoR,cybersecurity, concrete, additive manufacturing, the Fulbright Program, and the TRIO programs. Implementation and funding for CHIPS andScienceAct (P.L. 117-80) including issues related tofunding for the Regional Technology and Innovation Hub program. Issues related to HR 5933DeterrentAct. Medicaid. Name IMage Likeness legislation in collegiate athletics. NSF reimbursement rates. DOE reimbursement rates. Pell grants.

Education

FY 2026 appropriations including increased funding for university research and infrastructure, NSF Engines, biopharmaceutical manufacturing,biofuels, supply chain security, flood research, trauma, wastewater monitoring, the Regional Biocontainment Laboratories (RBLs),EPSCoR,cybersecurity, concrete, additive manufacturing, the Fulbright Program, and the TRIO programs. Implementation and funding for CHIPS andScienceAct (P.L. 117-80) including issues related tofunding for the Regional Technology and Innovation Hub program. Issues related to HR 5933DeterrentAct. Medicaid. Name IMage Likeness legislation in collegiate athletics. NSF reimbursement rates. DOE reimbursement rates. Pell grants.

Health Issues

FY 2026 appropriations including increased funding for university research and infrastructure, NSF Engines, biopharmaceutical manufacturing,biofuels, supply chain security, flood research, trauma, wastewater monitoring, the Regional Biocontainment Laboratories (RBLs),EPSCoR,cybersecurity, concrete, additive manufacturing, the Fulbright Program, and the TRIO programs. Implementation and funding for CHIPS andScienceAct (P.L. 117-80) including issues related tofunding for the Regional Technology and Innovation Hub program. Issues related to HR 5933DeterrentAct. Medicaid. Name IMage Likeness legislation in collegiate athletics. NSF reimbursement rates. DOE reimbursement rates. Pell grants.